Mississauga, Ontario – Rumours that Toronto-based Vasogen Incorporated’s new Celacade treatment for heart failure, also referred to as Acclaim II, is a failed drug and that clinical trials… more →
Medical History Todaywarrenh wrote 1 year ago: Mississauga, Ontario – Rumours that Toronto-based Vasogen Incorporated’s new Celacade tr … more →